Variable | Category | Univariate analysis OR (CI 95 %) | Multivariate analysis OR (CI 95 %) |
---|---|---|---|
Gender | Women | -------- | |
Men | 0.50 (0.17–1.48) | ||
Age | 0.97 (0.93–1.02) | ||
Age | ≤65 years | -------- | |
>65 years | 0.48 (0.20–1.11) | ||
BMI | 1.00 (0.92–1.08) | ||
BMI classification | Normal (18.5–24.9) | -------- | |
Overweight (25.0–29.9) | 1.37 (0.49–3.82) | ||
Obesity (≥30.0) | 0.87 (0.31–2.49) | ||
CAT | 1.15 (1.07–1.24) | 1.15 (1.07–1.24) | |
Time of evolution COPD (years) | 0.96 (0.91–1.03) | ||
Previous exacerbations | 2–3 | -------- | |
≥4 | 0.42 (0.11–1.65) | ||
FEV1(%) Postbronchodilation | 1.01 (0.98–1.03) | ||
GOLD stage | Mild-moderate | -------- | |
Severe-very severe | 0.96 (0.42–2.21) | ||
Dyspnea | ≤2 | -------- | |
>2 | 0.67 (0.27–1.63) | ||
BODEx index | ≤4 | -------- | |
>4 | 0.88 (0.38–2.07) | ||
Minutes walking a day | <30 | -------- | |
30–60 | 1.48 (0.54–4.07) | ||
>60 | 1.00 (0.36–2.78) | ||
Morisky-Green questionnaire | Compliant | -------- | |
Noncompliant | 3.13 (1.19–8.19) | ||
Significant cardiac comorbidity | No | -------- | |
Yes | 0.47 (0.17–1.36) | ||
Cardiovascular risk | None | -------- | |
Increased | 0.92 (0.28–3.102) | ||
High | 0.89 (0.27–2.89) | ||
Very/extremely high | 1.05 (0.33–3.38) | ||
Smoking status | Ex-smoker | -------- | |
Smoker | 1.98 (0.70–5.61) |